Phase 3 trials showed Vanrafia slowed the decline in kidney function for adults with the progressive autoimmune kidney ...

In an interview, Jackson Peter Kim, MD, clinical assistant professor in the Division of Nephrology at Stanford Health Care, ...

It’s déjà vu all over again. Just as the kidney disease space becomes increasingly competitive, Novartis has found itself intending to turn a statistical miss into a regulatory win. | It’s déjà vu all ...

A total of 340 biopsy-confirmed IgAN patients were randomised to daily oral Vanrafia or a placebo for approximately 132 weeks.

Lower kidney function is associated with elevated Alzheimer’s blood biomarkers, raising implications for dementia diagnosis ...

Kidney aging rarely draws attention until something goes wrong. Over time, these organs quietly lose strength, filter less efficiently, and struggle to keep the body balanced.

Kidney disease often creeps in silently, and many patients aren’t diagnosed until major damage is already done. New research ...

Comprehensive phosphorus management preserves residual renal function, considers dialysis modality, and minimizes intervention burden.

Many people assume that if a supplement is labelled “natural,” it must be safe. But that belief can be misleading. Several ...

Aims Heart failure (HF) often coexists with chronic kidney disease (CKD), impacting prognosis. This study aims to evaluate ...

What if a simple urine test could warn you about hidden kidney damage before symptoms even appear? It can-and that's exactly ...